CVS, FTC and Cigna
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
The Federal Trade Commission has published a report that found pharmacy benefit managers Caremark Rx LLC (CVS), Express Scripts and OptumRx marked up numerous specialty generic drugs by ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for cancer, AIDS, multiple sclerosis and other serious maladies far over the ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback